Teva Announces Launch of Camrese the Authorized Generic of Seasonique
Teva Pharmaceuticals USA, the U.S.–based generic arm of Teva Pharmaceuticals (NASDAQ: TEVA) announced that it will sell Camrese as the Authorized Generic of Seasonique® which is also manufactured by Teva Pharmaceuticals. This product will continue to be manufactured under the brand product's new drug application or NDA at the same facility where it is currently produced.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.